Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW)

CUSIP: 68236X118

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
3,808,951
Share change
+288,572
Total reported value
$195,399
Price per share
$0.05
Number of holders
11
Value change
+$15,251
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) as of Q2 2025

As of 30 Jun 2025, Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,808,951 shares. The largest 10 holders included LMR Partners LLP, DEERFIELD MANAGEMENT COMPANY, L.P., Davidson Kempner Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC, TORONTO DOMINION BANK, Man Group plc, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Alpine Global Management, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., and CLEAR STREET LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.